Skip to main content

The SeqBiome team also contributed to a publication by Irish and Swiss researchers in the journal Allergy entitled “Higher levels of bacterial DNA in serum associate with severe and fatal COVID-19”. Among other things, the study provides additional evidence for a loss of epithelial barrier function in patients with severe COVID-19.